Clinical Trial
-
Spine
Dr. Todd Lanman Begins Breakthrough Low Back Total Joint Replacement Clinical Trial in Beverly Hills with 3Spine, Inc.
BEVERLY HILLS, Calif., March 21, 2023 /PRNewswire/ — Todd Lanman, MD and Lanman Spinal Neurosurgery announced completion of the first lumbar total joint replacement procedure…
Read More » -
Spine
3Spine, Inc. Opens Innovative Clinical Trial for Spine Procedure with Pinehurst Surgical Clinic in Pinehurst, North Carolina
PINEHURST, N.C., March 6, 2023 –PRNewswire — Pinehurst Surgical Clinic today announced successful completion of the first series of cases in the BalancedBack…
Read More » -
Spine
Dr. Anton Jorgensen begins lumbar total Joint replacement clinical trial in San Antonio, TX with 3Spine, Inc.
Anton Jorgensen, MD SAN ANTONIO, March 6, 2023 –PRNewswire — Anton Jorgensen, MD and Ortho San Antonio announced today the first cases in the…
Read More » -
Spine
Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization
January 26, 2023 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces…
Read More » -
Spine
Spinal Stabilization Technologies Ltd. Announces Start of LOPAIN 2 Clinical Trial in South America for Lumbar Degenerative Disc Disease
KILKENNY, Ireland, Nov. 16, 2022 /OrthoSpineNews/ — Spinal Stabilization Technologies (SST) has announced the start of the LOPAIN2 clinical trial of the PerQdisc™…
Read More » -
Spine
3Spine, Inc. Opens Innovative Clinical Trial for Spine Procedure with Steamboat Orthopaedic & Spine Institute in Colorado
Dr. J. Alex Sielatycki, SOSI Spine Surgeon; Jessica Nyquist, SOSI Physician Assistant; and Dr. Scott Hodges, 3Spine Medical Director performed…
Read More » -
Neuro
Mainstay Medical Announces Publication of Three-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™
Data continue to show compelling efficacy and safety, including improvement on all key measures of pain and disability, as compared…
Read More » -
Spine
AxioMed LLC Submits Final Module III to the FDA Becoming the First and Only Lumbar Viscoelastic Total Disc Replacement Company to Complete a USA IDE Clinical Trial
On August 8, 2022, AxioMed LLC submitted to the FDA all the required documents for Module III. This is the…
Read More » -
Sports Medicine
Ortho Regenerative Technologies Announces Enrollment of First Patient in its U.S. Phase l/ll Rotator Cuff Tear Repair Clinical Trial
First patient surgery completed; additional surgeries already scheduled8 clinical centres now fully initiated and recruiting / screening for patients MONTREAL, July…
Read More » -
Biologics
BioRestorative Therapies Announces First Patient Enrolled for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
First Patient Enrollment Milestone Completed MELVILLE, NY., June 30, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:…
Read More » -
Spine
3Spine, Inc. Completes First US Surgeries
CHATTANOOGA, Tenn., June 29, 2022 /PRNewswire/ — 3Spine, Inc., a medical device company developing total joint replacement for the lumbar spine, today…
Read More » -
Spine
3Spine, Inc. Announces IDE Approval
CHATTANOOGA, Tenn., June 22, 2022 /PRNewswire/ — 3Spine, Inc., a medical device company developing total joint replacement for the lumbar spine, today…
Read More » -
Biologics
BioRestorative Therapies Announces Clinical Trial Contract with Second Site for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
MELVILLE, NY., June 22, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused…
Read More » -
Biologics
Ortho Regenerative Technologies Initiates Patients Recruitment For Its U.S. Phase I/II Rotator Cuff Tear Repair Clinical Trial
Contracting procedures completed for 6 of the 10 clinical trial sites5 sites fully activated, with ongoing patients’ screening and recruitment…
Read More » -
Spine
Clinical Trial to Test Replacement Devices for Two-Level Symptomatic Cervical Disc Disease
NEW YORK, June 1, 2022 /PRNewswire/ — A multicenter, prospective, randomized controlled trial is designed to assess the effectiveness of three different disc replacement…
Read More »